BROOKLINE INVESTMENTS, INC.
BROOKLINE INVESTMENTS, INC. is a Seed, Series A, Series B, Series C+, buyout and other fund in the US investing in Healthcare and real-estate.
- Stages
- Seed, Series A, Series B, Series C+, buyout, other
- Sectors
- Healthcare, real-estate
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 1999
- Assets under management
- $281.5M
Check size not disclosed
Thesis
Brookline Investments, Inc., established in 1999 and headquartered in Birmingham, Alabama, is an SEC-registered investment adviser and fund manager with a focus on private equity and venture capital. The firm manages 7 private funds with $222.5 million in gross asset value and $281.5 million in regulatory AUM. Their fund mix includes Venture Capital (4 funds), Private Equity (2 funds), and Other Private (1 fund). Management fees for private funds range from 0% to 2.0% per annum. The firm's investment banking division, Brookline Capital Markets, focuses on healthcare and biopharma. They have made at least one tracked investment in TRACON Pharmaceuticals (Series B, $27.0 million in 2014).
Common questions
Does BROOKLINE INVESTMENTS, INC. invest at the Seed stage?
Yes. BROOKLINE INVESTMENTS, INC. lists Seed, Series A, Series B, Series C+, buyout and other among the stages it invests in.
Where does BROOKLINE INVESTMENTS, INC. invest?
BROOKLINE INVESTMENTS, INC. invests in the US.